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INTRODUCTION
Pneumothorax is a frequently occurring clinical problem 
with a reported incidence of 18–28/100000 cases per year 
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Objective: This study aimed to assess the technical feasibility, procedural safety, and long-term therapeutic efficacy of a 
small-sized ambulatory thoracic vent (TV) device for the treatment of pneumothorax.
Materials and Methods: From November 2012 to July 2013, 18 consecutive patients (3 females, 15 males) aged 16–64 years 
(mean: 34.7 ± 14.9 years, median: 29 years) were enrolled prospectively. Of these, 15 patients had spontaneous pneumothorax 
and 3 had iatrogenic pneumothorax. A Tru-Close TV with a small-bore (11- or 13-Fr) catheter was inserted under bi-plane 
fluoroscopic assistance.
Results: Technical success was achieved in all patients. Complete lung re-expansion was achieved at 24 hours in 88.9% of 
patients (16/18 patients). All patients tolerated the procedure and no major complications occurred. The patients’ mean 
numeric pain intensity score was 2.4 (range: 0–5) in daily life activity during the TV treatment. All patients with spontaneous 
pneumothorax underwent outpatient follow-up. The mean time to TV removal was 4.7 (3–13) days. Early surgical conversion 
rate of 16.7% (3/18 patients) occurred in 2 patients with incomplete lung expansion and 1 patient with immediate 
pneumothorax recurrence post-TV removal; and late surgical conversion occurred in 2 of 18 patients (11.1%). The recurrence-
free long-term success rate was 72.2% (13/18 patients) during a 3-year follow-up period from November 2012 to June 2016.
Conclusion: TV application was a simple, safe, and technically feasible procedure in an outpatient clinic, with an acceptable 
long-term recurrence-free rate. Thus, TV could be useful for the immediate treatment of pneumothorax.
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in men and 1.2–6/100000 per year in women (1).
Pneumothorax is classified as either spontaneous or 
iatrogenic. Spontaneous pneumothorax can be further 
classified into primary cases, which involve healthy 
individuals without underlying lung disease, or secondary 
cases, which involve patients with underlying lung diseases 
such as pulmonary infection, emphysema, and malignancy. 
Traditional guidelines for the primary treatment of 
pneumothorax differ and include simple aspiration, small-
bore catheter (≤ 14 Fr) or chest tube (16–22 Fr) drainage, 
and ambulatory management with a small-bore catheter 
connected to Heimlich flutter valves (2, 3). Treatment 
via conventional chest tube drainage connected to a 
suction system is usually associated with hospitalization, 
immobilization, and discomfort. However, reliable patients 
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who do not want to be hospitalized can be treated in an 
outpatient department with a small-bore catheter attached 
to a Heimlich valve after lung reexpansion (2).
The thoracic vent (TV), a small-sized portable 
pneumothorax kit, is a minimally invasive, immediate 
salvage device for the treatment of pneumothorax that 
has been used successfully in several hospitals (4-6). 
With this device, immobilization and hospitalization are 
unnecessary because there is no need to connect the TV 
to an underwater seal device. Some studies, including 
a randomized comparison study by Röggla et al. (5), 
have assessed the effectiveness and advantage of TV vs. 
conventional tube drainage (6, 7). To date, however, few 
reports have addressed long-term recurrence rates with TV 
treatment.
This prospective study aimed to assess the technical 
feasibility, procedural safety, and long-term therapeutic 
efficacy of TV for the treatment of pneumothorax.
MATERIALS AND METHODS
Patients
The Institutional Review Board approved this prospective 
study (IRB approval number 3-2012-0114), and informed 
consent was obtained from all patients. Patients who 
presented with spontaneous or iatrogenic pneumothorax 
from November 2012 to July 2013 were enrolled. 
The exclusion criteria for the TV treatment were as 
follows: 1) hydropneumothorax, 2) hemopneumothorax, 
3) patient refusal, and 4) underlying pulmonary disease 
requiring supplemental oxygen.
A total of 18 patients (3 females, 15 males) between the 
ages of 16 and 64 years (mean: 34.7 ± 14.9 years, median: 
29 years) were enrolled. The mean time to intervention 
from the development of symptoms of pneumothorax was 
2.3 days (range: 1–6 days). The baseline characteristics 
of the patients are shown in Table 1. Fifteen patients had 
spontaneous pneumothorax (primary = 7, secondary = 8). 
The remaining 3 patients had iatrogenic pneumothorax (2 
cases of subclavian vein catheterization, and transthoracic 
needle biopsy).
Pneumothorax size was quantified using the equation 
reported by Collins et al. (8): pneumothorax size (%) = 4.2 
+ (4.7 x [A + B + C]), where A is the lung apex to apex, B 
is the upper half from the midpoint, and C is the lower half 
from the midpoint.
Table 1. Baseline Characteristics of Patients
Characteristics Patients (n = 18)
Age, mean ± SD (range) in years 34.7 ± 14.9 (16–64)
Sex (M:F) 15:3
Involved lung 
Right 10
Left 8
Etiology of pneumothorax
Spontaneous 15
Iatrogenic 3
Size of pneumothorax (%)
< 30 2
30–60 9
> 60 7
SD = standard deviation
Fig. 1. Thoracic vent. 
External dimensions of thoracic vent are 9.5 (length) x 2.5 (width) 
x 2 cm (height). Thoracic vent comprises flexible urethane catheter 
with outer diameter of 11-or 13-Fr and length of 10–13 cm and 
removable in-line trocar connected to 1-way valve. Red-colored 
diaphragm movement represents pneumothorax drainage according to 
gradient between intrathoracic and extracorporeal pressures.
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Fig. 2. Thoracic vent insertion under fluoroscopic guidance.
A. 21-gauge Chiba needle (arrow) is inserted into second to fourth intercostal space in midclavicular line. Following confirmation of needle 
position within pleural space under bi-plane fluoroscopic guidance, 0.018-inch hair-wire (arrowhead) and yellow sheath are introduced 
sequentially. B, C. Guide wire is then exchanged for 0.035-inch radiofocus stiff wire (arrow), and thoracic vent device is inserted over-wire with 
7-Fr dilator.
A
B
C
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Additionally, all patients participated in a personal 
interview about their experiences of pain at different 
activity levels of daily life (i.e., sleep, showering, deep 
breathing, going to the toilet, walking around) during TV 
treatment according to a numeric pain intensity scale (NPIS; 
range: 0–10).
Insertion and Management of the TV
We used the Tru-Close® TV (UreSil, Skokie, IL, USA) 
(Fig. 1), which comprises a flexible polyurethane catheter 
connected to a plastic chamber containing a 1-way valve. 
Positive pressure within the pleural space is indicated by a 
pressure-sensitive diaphragm contained within the plastic 
chamber (4, 6). TVs with small-bore (11- or 13-Fr) catheters 
were inserted under fluoroscopic guidance.
For traditional fluoroscopic-interventional device 
insertion, we used bi-plane fluoroscopy to ensure a safe 
and rapid procedure (Fig. 2). With the patient resting in 
the supine position, the puncture point was determined 
under bi-plane fluoroscopic guidance. After administering 
local anesthesia (2% lidocaine), the pneumothorax cavity 
was punctured with a 21-gauge Chiba needle (A&A M.D., 
Seongnam, Korea), usually into the second to fourth 
intercostal space along the midclavicular line. After 
confirming proper needle puncture within the pleural 
space under bi-plane fluoroscopy, a 0.018-inch hair-wire 
(slim wire, A&A M.D.) and yellow sheath (A&A M.D.) were 
introduced sequentially. The guide wire was then exchanged 
for a 0.035-inch, 80-cm-long stiff guide wire (Radifocus 
Guidewire; Terumo, Tokyo, Japan), and the TV device was 
finally inserted over-the-wire using a 7-Fr dilator.
Immediately after insertion of the TV, movement of 
the red-colored diaphragm indicated drainage of the 
pneumothorax based on the gradient between the 
intrathoracic and extracorporeal pressures. If the diaphragm 
did not move, the patient was encouraged to breathe 
deeply to enhance intrathoracic pressure, thus allowing the 
diaphragm movement; or diaphragm movement would be 
initiated by triggering pneumothorax aspiration with a 20-
mL syringe.
Movement of the red-colored diaphragm stopped upon 
full expansion of the affected lung. Subsequently, a chest 
radiography evaluation was performed under full expiration 
status. If full expansion of the involved lung was observed 
on a chest radiograph, an occlusion plug was applied 
to evaluate further air leakage during follow-up chest 
radiography on the next day. Removal of the entire device 
was recommended if follow-up chest radiography indicated 
all negative signs on the occlusion plug test and a fully 
expanded lung without pneumothorax recurrence.
Technical success was defined as successful placement 
of the TV within the pleural cavity without procedure-
related complications. Clinical success after TV insertion 
was defined as a complete resolution of baseline clinical 
symptoms and/or signs related to pneumothorax. Chest 
radiographs were taken immediately after TV insertion 
and daily thereafter to assess re-expansion of the affected 
lung. Clinically stable patients were discharged from the 
hospital with the TV in place. Oral medications (analgesics, 
non-steroid anti-inflammatory drug, and anti-acid) were 
prescribed and the patients were followed-up at an 
outpatient clinic.
All enrolled patients underwent follow-up for a mean 
duration of 36.4 months (range: 19–42 months) from 
November 2012 to June 2016. Kaplan-Meier analysis was 
used to estimate the probability of being recurrence-free in 
the patients with TV insertion.
RESULTS
Table 2 summarizes the results of TV insertion in this 
study, with a mean follow-up duration of 36.4 months 
(range: 19–42 months).
Table 2. Outcomes of TV insertion (n = 18)
Outcome Variables Results
Technical success rate (%) 100 (18/18)
Clinical success rate (%) 88.9 (16/18) 
Procedure-related complication rate (%) 0 (0/18)
Mean NPIS value 2.4 (0–5)
Sleep 1.5
Taking shower 3.8
Deep breathing 2.6
Going to toilet 1.7
Walking around 2.4
Mean time of removal of TV (days) 4.7 (3–13)
Total surgical conversion rate (%) 27.8 (5/18)
Early surgical conversion patient 16.7 (3/18)
Incomplete lung expansion 11.1 (2/18)
Immediate recurrence after removal of TV 5.6 (1/18)
Late surgical conversion patient* 11.1 (2/18)
Recurrence rate (%) 18.7 (3/16)
Recurrence free overall success rate (%) 72.2 (13/18)
*1 patient underwent tube thoracotomy instead of surgery due to 
multiple cystic lung disease. NPIS = numerical pain index score, 
TV = thoracic vent
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Thoracic vent insertion was technically successful without 
complications in all patients. Clinical success (i.e., complete 
re-expansion of the affected lung) was achieved in 88.9% 
(16/18) of cases at 24 hours. The degree of pain at 
different activity levels is shown in Table 2; and the mean 
NPIS during TV treatment was 2.4 (range: 0–5). All patients 
with spontaneous pneumothorax were followed-up on an 
outpatient basis. The mean time to TV removal was 4.7 days 
(range: 3–13 days). Of the 18 patients, 2 were converted 
to video-assisted thoracoscopic (VATS) wedge resection of 
the affected lung because of incomplete lung expansion 
at 5 days after TV insertion (treatment failure), and 1 
underwent VATS wedge resection and pleurodesis because of 
an immediate recurrence at 17 days after TV removal (early 
recurrence). During follow-up of the remaining 15 patients, 
2 experienced pneumothorax recurrence at 19 and 25 
months after TV removal, respectively (late recurrence). The 
former patient underwent VATS wedge resection for multiple 
bullae, and the latter was treated via tube thoracotomy. 
The latter patient suffered from multiple cystic lung disease 
and was managed by repeated tube thoracotomy instead of 
surgery. Kaplan-Meier analysis of freedom from recurrence 
for patients with TV insertion is shown in Figure 3. The 
recurrence-free probability of pneumothorax at 1, 2, and 3 
years was 83.3, 77.8, and 72.2%, respectively. The mean 
freedom from recurrent pneumothorax was 32.9 months (95% 
confidence interval, 25.7–40.1 months).
DISCUSSION
In some hospitals, needle aspiration is used to treat 
small pneumothorax on an outpatient basis. Although 
needle aspiration is a simple procedure, it is difficult to 
assess whether there is a persistent air leak after needle 
aspiration. Therefore, minimally invasive chest tube drainage 
is considered more clinically useful in treating patients with 
a large pneumothorax. Treatment of pneumothorax with a 
valved device is not a new concept. Given the advantages 
of mobility and outpatient ambulatory management, 
the well known Heimlich valve has been used in several 
hospitals (9). However, small-bore catheters attached to 
flutter valves have reported problems such as difficulty 
of air leak estimation (i.e., caregivers should disconnect 
the drain and connect it to an underwater drain to see if 
there is any air leak), possibility of the valve falling off 
the tube or valve dislodgement, and catheter kinking (4, 
10, 11). As a modality for the ambulatory management of 
spontaneous pneumothorax, TV was designed to overcome 
problems associated with the small-bore catheter system. 
Several recent studies have shown the safety and efficacy 
of a minimally invasive approach involving TV (4-6, 12-
15). Since monitoring for air leaks is possible, TV can be 
removed after the confirmation of pneumothorax resolution. 
Furthermore, since TV uses a one-way valve within a plastic 
chamber that is permanently attached to a catheter, it is 
not associated with the problem of valve disconnection. 
Under these circumstances, we conducted this study to 
assess the effectiveness and long-term therapeutic efficacy 
of TV treatment.
In this article, we found that TV is not only safe and 
effective for the immediate treatment of pneumothorax, but 
also provides a high long-term recurrence-free success rate. 
The rate of incomplete expansion was very low (11.1%, 2 
of 18 patients), and only 1 patient underwent surgery after 
TV removal because of an immediate recurrence. The former 
two patients had a very large amount of pneumothorax 
(99.9 and 73.4%, respectively) with subpleural fibrosis 
and bullae, and the latter patient had a moderate amount 
of pneumothorax (39.2%) with several subpleural bullae. 
The 3-year follow-up of patients treated with TV in this 
prospective study revealed a high recurrence-free overall 
success rate (72.2%, 13 of 18 patients). In the patients 
with late surgical coversion, initial pneumothorax was also 
successfully treated with TV, but rupture of another cystic 
lesion or bulla resulted in recurrent pneumothorax.
In our patients, hospitalization on the day of TV insertion 
was avoided, and early ambulation was possible. Most of 
those patients reported little pain associated with the TV 
Fig. 3. Kaplan-Meier analysis of long-term freedom from 
recurrence after thoracic vent insertion.
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device and could lead a normal daily life, including sleep, 
taking a shower, going to the toilet, and walking around. 
On the NPIS (0–10), the mean value was 2.4 (range: 0–5) 
for different activity levels in daily life. Thus, patients with 
an inserted TV can receive treatment on an outpatient basis 
and are not required to stop working or attending school. 
A prospective trial to compare the TV treatment with other 
treatment options is needed; however, the consequent 
advantage of outpatient TV treatment can reduce medical 
expense and provide economic benefits to patients (6).
We achieved a high technical success rate without 
complication (100%, 18 of 18 patients) because the 
procedure was performed under bi-plane fluoroscopic 
guidance to minimize the risk of deep penetration of the 
puncture needle. Moreover, the procedure is relatively 
simple to perform, as compared to chest tube insertion 
or surgery; therefore, it is less burdensome for patients, 
as well as physicians. Several TV-associated complications 
have been reported, including device-occlusion caused 
by clots or sludges, thoracic wall hematoma caused by 
malpuncture or repeated puncture, hemothorax caused by 
unintended arterial laceration, and bronchopleural fistula 
caused by misuse in a patient with pleural adhesion-
associated pneumothorax (4, 5, 16, 17); however, no major 
complications were observed in our study. 
Röggla et al. (5) conducted a randomized study to 
compare TV treatment with intercostal tube drainage in the 
management of pneumothorax. They suggested that TV is as 
effective as intercostal tube drainage, with no significant 
differences in the rate of reexpansion and complications. 
Furthermore, the TV patient group reported less pain than 
the intercostal tube drainage group. Majority of the TV 
patient group were treated on an outpatient basis. These 
authors accordingly recommended TV as the first-line 
treatment of choice for pneumothorax. However, follow-
up data or recurrence rate according to treatment was not 
evaluated. Recurrence rates of 7–24% are reported for 
patients treated by small-bore catheter with Heimlich valve 
system (18). In our study, the 3-year follow-up recurrence 
rate of TV treatment was 18.7% (3/16 patients), which 
was not significantly different from the recurrence rates of 
small-bore catheter system. This result indicated that TV 
treatment is as effective in terms of recurrence as the small-
bore catheter system.
Unfortunately, this study suffers from the following 
limitations. First, the study population was relatively small 
and the study was conducted in a single center. Second, 
we did not directly compare the results of our study with 
those of other treatment methods such as simple needle 
aspiration, intercostal chest tube drainage, small-bore 
catheter system, and VATS. However, we performed a 
prospective investigation of this procedure with a long-
term follow up period. The outcomes of this study therefore 
provide fairly effective clinical results. Further randomized 
comparison trials with a larger population group are 
required to confirm the current results.
In conclusion, the use of a small-bore ambulatory 
TV can be indicated for the outpatient management of 
pneumothorax. This device could also be a useful primary 
treatment for spontaneous or iatrogenic pneumothorax with 
an acceptable long-term recurrence-free rate.
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